{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T15:13:16Z","timestamp":1664982796184},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00115-022-01393-0","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T06:02:47Z","timestamp":1663567367000},"page":"1062-1073","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seltene Erkrankungen in der Differenzialdiagnose bei Myalgien"],"prefix":"10.1007","volume":"93","author":[{"given":"D.","family":"Emmert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Rasche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sellin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Brunkhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. T. A.","family":"Bender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"B\u00f6rsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Grigull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"M\u00fccke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"key":"1393_CR1","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1007\/s11606-008-0636-7","volume":"23","author":"C Buettner","year":"2008","unstructured":"Buettner\u00a0C, Davis\u00a0RB, Leveille\u00a0SG, Mittleman\u00a0MA, Mukamal\u00a0KJ (2008) Prevalence of musculoskeletal pain and statin use. J\u00a0Gen Intern Med 23:1182\u20131186","journal-title":"J Gen Intern Med"},{"key":"1393_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s15016-020-7445-6","volume":"31","author":"M M\u00fccke","year":"2020","unstructured":"M\u00fccke\u00a0M, Emmert\u00a0D, Rasche\u00a0T, Conrad\u00a0R (2020) Spurensuche bei Patienten ohne Diagnose. Neurotransmitter 31:17\u201321","journal-title":"Neurotransmitter"},{"key":"1393_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s13311-018-00675-3","volume":"15","author":"J Hamel","year":"2018","unstructured":"Hamel\u00a0J, Tawil\u00a0R (2018) Facioscapulohumeral muscular dystrophy: update on pathogenesis and future treatments. Neurotherapeutics 15:863\u2013871","journal-title":"Neurotherapeutics"},{"key":"1393_CR4","volume-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"M Deschauer","year":"2016","unstructured":"Deschauer\u00a0M et al (2016) S1-Leitlinie Diagnostik von Myopathien. In: Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie (www.dgn.org\/leitlinien (abgerufen am 08.11.2019))"},{"key":"1393_CR5","first-page":"1916","volume":"22","author":"JM Statland","year":"2016","unstructured":"Statland\u00a0JM, Tawil\u00a0R (2016) Facioscapulohumeral muscular dystrophy. Contin Minneap Minn 22:1916\u20131931","journal-title":"Contin Minneap Minn"},{"key":"1393_CR6","volume-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"C Schneider-Gold","year":"2017","unstructured":"Schneider-Gold\u00a0C et al (2017) S1-Leitlinie Myotone Dystrophien, nicht dystrophe Myotonien und periodische Paralysen. In: Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie (www.dgn.org\/leitlinien)"},{"key":"1393_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11940-016-0434-1","volume":"18","author":"CA Smith","year":"2016","unstructured":"Smith\u00a0CA, Gutmann\u00a0L (2016) Myotonic dystrophy type 1 management and therapeutics. Curr Treat Options Neurol 18:52","journal-title":"Curr Treat Options Neurol"},{"key":"1393_CR8","first-page":"46","volume":"15","author":"C Hahn","year":"2016","unstructured":"Hahn\u00a0C, Salajegheh\u00a0MK (2016) Myotonic disorders: a review article. Iran J Neurol 15:46\u201353","journal-title":"Iran J Neurol"},{"key":"1393_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/mus.26077","volume":"58","author":"T Liewluck","year":"2018","unstructured":"Liewluck\u00a0T, Milone\u00a0M (2018) Untangling the complexity of limb-girdle muscular dystrophies. Muscle Nerve 58:167\u2013177","journal-title":"Muscle Nerve"},{"key":"1393_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-46892-0","volume-title":"Neurologie","year":"2016","unstructured":"Hacke\u00a0W (Hrsg) (2016) Neurologie https:\/\/doi.org\/10.1007\/978-3-662-46892-0"},{"key":"1393_CR11","volume-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"D Heu\u00df","year":"2020","unstructured":"Heu\u00df\u00a0D et al (2020) Diagnostik und Differenzialdiagnose bei Myalgien, S1-Leitlinie. In: Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie (www.dgn.org\/leitlinien (abgerufen am 04.04.2020).)"},{"key":"1393_CR12","volume-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"H-M Meinck","year":"2017","unstructured":"Meinck\u00a0H\u2011M et al (2017) S1-Leitlinie Stiff-Man-Syndrom. In: Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie (www.dgn.org\/leitlinien (abgerufen am 08.01.2019).)"},{"key":"1393_CR13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00115-003-1619-x","volume":"75","author":"D Fischer","year":"2004","unstructured":"Fischer\u00a0D, Schr\u00f6der\u00a0R (2004) Isaacs\u2019 syndrome. Diagnosis and differential diagnosis of neuromyotonia. Nervenarzt 75:531\u2013535","journal-title":"Nervenarzt"},{"key":"1393_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/mus.24632","volume":"52","author":"A Ahmed","year":"2015","unstructured":"Ahmed\u00a0A, Simmons\u00a0Z (2015) Isaacs syndrome: a review. Muscle Nerve 52:5\u201312","journal-title":"Muscle Nerve"},{"key":"1393_CR15","series-title":"GeneReviews\u00ae","volume-title":"Glycogen storage disease type V","author":"MA Mart\u00edn","year":"1993","unstructured":"Mart\u00edn\u00a0MA, Luc\u00eda\u00a0A, Arenas\u00a0J, Andreu\u00a0AL (1993) Glycogen storage disease type V. GeneReviews\u00ae"},{"key":"1393_CR16","volume-title":"F\u00e4lle Seltene Erkrankungen: Patienten ohne Diagnose","author":"T Bender","year":"2018","unstructured":"Bender\u00a0T (2018) F\u00e4lle Seltene Erkrankungen: Patienten ohne Diagnose, 1.\u00a0Aufl. Elsevier, M\u00fcnchen","edition":"1"},{"key":"1393_CR17","first-page":"78","volume":"32","author":"A Toscano","year":"2013","unstructured":"Toscano\u00a0A, Montagnese\u00a0F, Musumeci\u00a0O (2013) Early is better? A new algorithm for early diagnosis in late onset Pompe disease (LOPD). Acta Myol 32:78\u201381","journal-title":"Acta Myol"},{"key":"1393_CR18","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S0960-8966(98)00088-1","volume":"8","author":"KM Bushby","year":"1998","unstructured":"Bushby\u00a0KM, Pollitt\u00a0C, Johnson\u00a0MA, Rogers\u00a0MT, Chinnery\u00a0PF (1998) Muscle pain as a\u00a0prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports. Neuromuscul Disord 8:574\u2013579","journal-title":"Neuromuscul. Disord."},{"key":"1393_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-3-662-57295-5_9","volume-title":"P\u00e4diatrie","author":"AM Kaindl","year":"2019","unstructured":"Kaindl\u00a0AM, Schara\u00a0U, Sch\u00fclke-Gerstenfeld\u00a0M (2019) Neuromuskul\u00e4re Erkrankungen. In: Speer\u00a0CP, Gahr\u00a0M, D\u00f6tsch\u00a0J (Hrsg) P\u00e4diatrie. Springer, Berlin, Heidelberg, S 221\u2013235"},{"key":"1393_CR20","first-page":"58","volume":"15","author":"PA Torres","year":"2015","unstructured":"Torres\u00a0PA, Helmstetter\u00a0JA, Kaye\u00a0AM, Kaye\u00a0AD (2015) Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner\u00a0J 15:58\u201369","journal-title":"Ochsner J"},{"key":"1393_CR21","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s10072-018-3515-y","volume":"39","author":"R Singh","year":"2018","unstructured":"Singh\u00a0R, Das\u00a0P, Kaur\u00a0U, Misra\u00a0A, Choudhury\u00a0A, Manna\u00a0S, Gaude\u00a0R, Gautam\u00a0D, Gambhir\u00a0IS, Chakrabarti\u00a0SS (2018) Morvan\u2019s syndrome\u2014is a\u00a0pathogen behind the curtain? Neurol Sci 39:1965\u20131969","journal-title":"Neurol Sci"},{"key":"1393_CR22","unstructured":"Wiendl H Myositissyndrome S2k Leitlinie f\u00fcr Diagnostik und Therapie in der Neurologie, AWMF-Registernummer 030\/054. www.awmf.org\/leitlinien. Zugegriffen: 8. Nov. 2019"},{"key":"1393_CR23","first-page":"1","volume-title":"Klin. Neurol","author":"J W\u00f6hrle","year":"2017","unstructured":"W\u00f6hrle\u00a0J (2017) Elektromyografie (EMG). In: Berlit\u00a0P (Hrsg) Klin. Neurol. Springer, Berlin, Heidelberg, S\u00a01\u20137"},{"key":"1393_CR24","doi-asserted-by":"publisher","first-page":"e1298","DOI":"10.1259\/bjr\/14063641","volume":"85","author":"DJ Theodorou","year":"2012","unstructured":"Theodorou\u00a0DJ, Theodorou\u00a0SJ, Kakitsubata\u00a0Y (2012) Skeletal muscle disease: patterns of MRI appearances. Br J Radiol 85:e1298\u2013e1308","journal-title":"Br J Radiol"},{"key":"1393_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/mus.27081","volume":"63","author":"J Wijntjes","year":"2021","unstructured":"Wijntjes\u00a0J, van Alfen\u00a0N (2021) Muscle ultrasound: present state and future opportunities. Muscle Nerve 63:455\u2013466","journal-title":"Muscle Nerve"},{"key":"1393_CR26","doi-asserted-by":"publisher","first-page":"913","DOI":"10.4103\/2230-8210.117215","volume":"17","author":"A Gupta","year":"2013","unstructured":"Gupta\u00a0A, Gupta\u00a0Y (2013) Glucocorticoid-induced myopathy: pathophysiology, diagnosis, and treatment. Indian J Endocrinol Metab 17:913\u2013916","journal-title":"Indian J Endocrinol Metab"},{"key":"1393_CR27","first-page":"3","volume-title":"The procedure of muscle biopsy in Muscle Biospy a\u00a0practical approach","author":"V Dubowitz","year":"2007","unstructured":"Dubowitz\u00a0V, Sewry\u00a0C (2007) The procedure of muscle biopsy in Muscle Biospy a\u00a0practical approach, 3.\u00a0Aufl. Elsevier Saunders, , S\u00a03\u201320","edition":"3"},{"key":"1393_CR28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.apmr.2007.08.153","volume":"89","author":"MP Jensen","year":"2008","unstructured":"Jensen\u00a0MP, Hoffman\u00a0AJ, Stoelb\u00a0BL, Abresch\u00a0RT, Carter\u00a0GT, McDonald\u00a0CM (2008) Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy. Arch Phys Med Rehabil 89:320\u2013328","journal-title":"Arch Phys Med Rehabil"},{"key":"1393_CR29","unstructured":"https:\/\/dgn.org\/wp-content\/uploads\/2013\/01\/030051_CP_Myalgien_2020.pdf. Zugegriffen: 24. Febr. 2022"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-022-01393-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-022-01393-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-022-01393-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T14:56:46Z","timestamp":1664981806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-022-01393-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1393"],"URL":"https:\/\/doi.org\/10.1007\/s00115-022-01393-0","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,19]]},"assertion":[{"value":"19 September 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>D.\u00a0Emmert<\/b>: A.\u00a0Finanzielle Interessen: Patente, Gesch\u00e4ftsanteile, Aktien o.\u202f\u00c4. an einer im Medizinbereich aktiven Firma: Aktien BioNTech. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Assistenzarzt Institut f\u00fcr Virologie, Universit\u00e4tsklinikum Bonn, Doktorand Zentrum f\u00fcr seltene Erkrankungen Bonn.<b>T.\u00a0Rasche<\/b>: A.\u00a0Finanzielle Interessen: T.\u00a0Rasche gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Assistenzarzt Neurologie, Uniklinikum M\u00fcnster.<b>J.\u00a0Sellin<\/b>: A.\u00a0Finanzielle Interessen: J.\u00a0Sellin gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Leiterin der Forschungsgruppe Digitale medizinische Anwendungen, Institut f\u00fcr Digitale Allgemeinmedizin, Uniklinikum Aachen.<b>R.\u00a0Brunkhorst<\/b>: A.\u00a0Finanzielle Interessen: R.\u00a0Brunkhorst gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Oberarzt, Klinik f\u00fcr Neurologie, Universit\u00e4tsklinikum RWTH Aachen.<b>T.\u00a0T.\u00a0A.\u00a0Bender<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar: Shire\/Takeda. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Assistenzarzt in Weiterbildung Facharzt f\u00fcr Humangenetik, Arbeitgeber: Universit\u00e4tsklinikum Bonn.<b>N.\u00a0Weinstock<\/b>: A.\u00a0Finanzielle Interessen: N.\u00a0Weinstock gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Koordinatorin am Zentrum f\u00fcr seltene Erkrankungen Bonn, Universit\u00e4tsklinikum Bonn, Venusberg-Campus\u00a01, 53127 Bonn.<b>N.\u00a0B\u00f6rsch<\/b>: A.\u00a0Finanzielle Interessen: N.\u00a0B\u00f6rsch gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellte \u00c4rztin in Weiterbildung zur Fach\u00e4rztin f\u00fcr Allgemeinmedizin in der Praxis M\u00fccke, Bonn | Mitgliedschaften: Wissenschaftlicher medizinischer Beirat der Ehlers-Danlos-Selbsthilfe e.\u202fV., BDI (Berufsverband Deutscher Internistinnen und Internisten e.\u202fV.).<b>L.\u00a0Grigull<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: Shire Takeda und Sanofi Genzyme.\u00a0\u2013 Patente, Gesch\u00e4ftsanteile, Aktien o.\u202f\u00c4. an einer im Medizinbereich aktiven Firma: Mitgesellschafter KImedi GmbH. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: bis\u00a006\/2020 Kinderarzt, Medizinische Hochschule Hannover, Abteilung f\u00fcr P\u00e4diatrische H\u00e4matologie und Onkologie, seit\u00a007\/2020 Kinderarzt, Universit\u00e4tsklinikum Bonn, Sektionsleitung \u201eKinder\u201c, Zentrum f\u00fcr seltene Erkrankungen, seit\u00a010\/2021 Kinderarzt, Universit\u00e4tsklinikum Bonn, Institutsleitung, Zentrum f\u00fcr seltene Erkrankung | Mitgliedschaft: GMA (Gesellschaft f\u00fcr Medizinische Ausbildung).<b>R.\u00a0Conrad<\/b>: A.\u00a0Finanzielle Interessen: Vortragshonorar von Takeda.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Ambulanz- und Forschungsleiter, Klinik und Poliklinik f\u00fcr Psychosomatische Medizin und Psychotherapie, Universit\u00e4tsklinik Bonn, Deutsches Kollegium f\u00fcr Psychosomatische Medizin (DKPM).<b>M.\u00a0M\u00fccke<\/b>: A.\u00a0Finanzielle Interessen: Vortragshonorar und Reisekosten der Firma Takeda und StadaPharm. \u2013\u00a0Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00c4.: Firma Takeda und StadaPharm.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Niedergelassener Allgemeinmediziner, Universit\u00e4tsprofessor des Instituts f\u00fcr Digitale Allgemeinmedizin, Vorstandsvorsitzender des Zentrums f\u00fcr Seltene Erkrankungen Aachen (ZSEA), Mitglied der DEGAM St\u00e4ndigen Leitlinienkomission, Vorstandsmitglied der Arbeitsgemeinschaft Seltene Erkrankungen Deutschland (AG ZSE).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}